Cagrilintide is a long-acting amylin analog peptide designed to treat obesity and type 2 diabetes by promoting satiety, reducing appetite, and slowing gastric emptying. It is often combined with semaglutide (forming "CagriSema") to enhance weight loss and glycemic control.
*PRODUCT USAGE: All Products on this website are intended for Research Only. This Designation allows the use of research chemicals sticktly for in vitro testing and laboratory experimentation only. All products available on this website are for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. These products should only be handled by licensed, qualified professional/ The products are not a drug, food or costmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
